User's Manual
Table Of Contents
- 1. General description
- 2. Indications
- 3. Contraindications
- 4. Warnings and precautions
- 5. Adverse events
- 6. Clinical studies
- 7. Patient selection and treatment
- 8. Patient counselling information
- 9. Declaration of conformity
- 10. Physician guidelines
- 11. Patient information
- 12. How supplied
- 13. Device description
- 14. Implant procedure
- 14.1. Necessary equipment
- 14.2. Packaging
- 14.3. Optional equipment
- 14.4. Before opening the package
- 14.5. Prior to implantation
- 14.6. Device placement
- 14.7. Choosing the type of lead
- 14.8. Shock configuration (+ -> -)
- 14.9. Measurement of thresholds at implant
- 14.10. Leads connection
- 14.11. Device implantation
- 14.12. Tests and programming
- 15. Special modes
- 16. Main functions
- 17. Patient follow-up
- 18. Supplemental Information
- 19. Physical characteristics
- 20. Electrical characteristics
- 21. Programmable parameters
- 22. Non programmable parameters
- 23. Limited warranty
- 24. Patents
- 25. Explanation of symbols
22. NON PROGRAMMABLE PARAMETERS
22. NON PROGRAMMABLE PARAMETERS
Interval Values
Committed period 95 ms (± 5 ms)
Atrial refractory periods Values
Post atrial sensing 47 ms (± 16 ms)
Post atrial pacing 109 ms (± 4 ms)
Ventricular refractory periods Values
Post ventricular sensing 95 ms (± 16 ms)
Post ventricular pacing 220 ms (± 4 ms)
Post atrial pacing (blanking) 16 ms (± 3 ms)
Tachycardia criteria Values
Window of PR association 63 ms (± 1 ms)
Therapies Values
Waveform
(1)
Constant tilt (50% - 50%)
Stored energy for the Max. shock 42 J
Pacing amplitude during ATP
therapies
7 V (Actual value at 300 ms: 5.3 V )
Anti-PMT protection Termin
(1) The device has 50% tilt in each phase thus delivers 94% of stored energy. Each phase is limited to
10 ms duration.
66
SORIN – PLATINIUM CRT-D – U459A